Polaryx Therapeutics Inc

Research Polaryx Therapeutics Inc (PLYX) on Bullrun: market cap USD 126.11M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPLYX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 126.11M
• Financial periodFY2025
• Net income-USD 8.99M

Valuation Snapshot

latest market cap is USD 126.11M.

About Polaryx Therapeutics Inc

Polaryx Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal storage disorders in the United States. Its pipeline includes PLX-100, a preclinical stage orally administrable combination therapy; PLX-200, a repurposed oral small molecule for the treatment of LSDs; PLX-300, a preclinical stage orally administrable combination therapy;

Frequently asked questions

What is Polaryx Therapeutics Inc's market cap?

Polaryx Therapeutics Inc's market capitalization is USD 126.11M.

What does Polaryx Therapeutics Inc do?

Polaryx Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal storage disorders in the United States.